My ePortfolio Register   
 

Abstract | Full HTML Article | PDF ecancer 10 686 / DOI: 10.3332/ecancer.2016.686

Special Issue

Close cooperation with Health Technology Assessment expertise is crucial for implementation and ultimately reimbursement of innovations in oncology

The Organisation of European Cancer Institutes OECI working group on Health Economics and Cost Benefit in Oncology suggests four actions that are needed to improve alignment and integration between clinicians, researchers, and Health Technology Assessment (HTA) experts and agencies: 1) HTA expertise is necessary close to or within the comprehensive cancer centres (CCC); 2) HTA expertise should be physically present throughout the translational research process; 3) Appropriate knowledge is necessary within the research staff; 4) Close cooperation between translational researchers, clinicians, and health economists guarantees clinical ownership.

Fulfilling these conditions may help the translational research field in oncology to interact with agencies and efficiently move innovative technologies through the translational research stages into that of implementation and diffusion. This brings innovative treatments faster to the patient with a greater chance of reimbursement.

Keywords: Health Technology Assessment, collaboration, innovations, oncology practice

Loading Article Metrics ... Please wait

Related articles

Review: Bringing a humanistic approach to cancer clinical trials

Abstract | Full Article | PDF Published: 18 May 2017 / DOI: 10.3332/ecancer.2017.738

Review: Nursing diagnoses in adult/elderly patients undergoing outpatient antineoplastic chemotherapy: a review

Abstract | Full Article | PDF | Portuguese Published: 03 May 2017 / DOI: 10.3332/ecancer.2017.736

Review: Tobacco in post-conflict settings: the case of Iraq

Abstract | Full Article | PDF Published: 28 Apr 2017 / DOI: 10.3332/ecancer.2017.735

Image Report: Brachytherapy and anterior segment imaging in iris melanoma

Abstract | Full Article | PDF Published: 18 Apr 2017 / DOI: 10.3332/ecancer.2017.734

Case Report: Unusual tumour ablations: report of difficult and interesting cases

Abstract | Full Article | PDF Published: 18 Apr 2017 / DOI: 10.3332/ecancer.2017.733



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

Cancer Intelligence